News

The FDA has approved Gamifant as the first-ever treatment for macrophage activation syndrome in Still’s disease for adults ...
Regeneron Pharmaceuticals said on Wednesday the U.S. Food and Drug Administration has approved its drug for a type of blood ...
Regeneron Pharmaceuticals has received accelerated FDA approval for Lynozyfic, a new bispecific antibody treatment for adults with relapsed or refractory multiple myeloma who have undergone at least ...
Breaking down what patients should know about each FDA therapeutic approval from June 2025 across various oncology ...
China’s National Medical Products Administration (NMPA) has approved four new drugs developed by local biopharma companies, ...
Utah biochemist Wesley Sundquist has achieved yet another milestone with the Food and Drug Administration approval of an ...
A common drug used for inflammatory skin conditions may hold the key to treating both alcohol addiction and pain sensitivity.
The Food and Drug Administration (FDA) has approved an updated label for Amyvid (florbetapir F 18 injection) to support Alzheimer disease diagnosis in patients.
Rett syndrome is a devastating rare genetic childhood disorder primarily affecting girls. Merely 1 out of 10,000 girls are ...
An investigation has uncovered evidence of significant misreporting, raising new concerns about the approval and long-term ...
Aquestive Therapeutics, Inc. (NASDAQ:AQST) is among the best growth stocks to invest in for the next 5 years. Analysts at H.C ...